TTY Biopharm Company Limited announced that Kao, Jung-Liang will be replaced with Chiang, Yung-Min, Senior Manager of Finance Department of Synmosa Biopharma Corporation, as internal audit officer, effective November 7, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
76.6 TWD | +0.13% | +0.79% | -4.73% |
Mar. 14 | TTY Biopharm Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 08 | TTY Biopharm Company Limited Announces Change of CFO and Financial Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.73% | 584M | |
+25.83% | 661B | |
+26.01% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.64% | 231B | |
+5.34% | 200B | |
-9.00% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 4105 Stock
- News TTY Biopharm Company Limited
- TTY Biopharm Company Limited Announces Internal Audit Officer Changes, Effective November 7, 2022